Abstract | OBJECTIVE: STUDY DESIGN: The patients were boys and girls age 6 to 17 years. ADHD subtype diagnoses (ie, inattentive, hyperactive-impulsive, combined) were based on criteria published in the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV). Patients received modafinil (170 to 425 mg) or placebo once daily for 7 to 9 weeks. Efficacy assessment used the Attention-Deficit/Hyperactivity Disorder Rating Scale-IV ( ADHD-RS-IV) School and Home Versions, Clinical Global Impression of Improvement scale (CGI-I), and Conners' Parent Rating Scale-Revised: Short Form (CPRS-R:S). RESULTS: A total of 638 patients received modafinil (n = 423) or placebo (n = 215). The inattentive, hyperactive-impulsive, and combined subtypes included 187 (30%), 27 (4%), and 403 (65%) patients, respectively. Modafinil (vs placebo) significantly improved mean total scores for the ADHD-RS-IV School and Home Versions for the inattentive (change from baseline: School, modafinil, -15.7, placebo, -7.1; Home, modafinil, -13.8, placebo, -5.9) and combined subtypes (School, -16.5 vs -8.8; Home, -15.7 vs -7.6). Modafinil was associated with greater improvements on the CGI-I and improved CPRS-R:S subscale scores in inattentive and combined subtypes. CONCLUSIONS:
Modafinil improved ADHD symptoms and behaviors in patients with the inattentive and combined subtypes as determined by teachers, investigators, and parents.
|
Authors | Joseph Biederman, Steven R Pliszka |
Journal | The Journal of pediatrics
(J Pediatr)
Vol. 152
Issue 3
Pg. 394-9
(Mar 2008)
ISSN: 1097-6833 [Electronic] United States |
PMID | 18280848
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Benzhydryl Compounds
- Central Nervous System Stimulants
- Modafinil
|
Topics |
- Adolescent
- Age Factors
- Attention Deficit Disorder with Hyperactivity
(diagnosis, drug therapy)
- Benzhydryl Compounds
(administration & dosage)
- Central Nervous System Stimulants
(administration & dosage)
- Child
- Confidence Intervals
- Dose-Response Relationship, Drug
- Double-Blind Method
- Drug Administration Schedule
- Female
- Follow-Up Studies
- Humans
- Male
- Modafinil
- Neuropsychological Tests
- Probability
- Randomized Controlled Trials as Topic
- Reference Values
- Risk Assessment
- Severity of Illness Index
- Sex Factors
- Treatment Outcome
|